Coherus BioSciences

Coherus Oncology is a commercial-stage biopharmaceutical company focused on developing next-generation immuno-oncology combination therapies to improve treatment outcomes for cancer patients. Their portfolio includes FDA-approved therapies and multiple clinical-stage drug candidates targeting the tumor microenvironment.